Matt Wecker is currently working with Maria Ghirardi on the optimization of hydrogenases and production of hydrogen using the photosynthetic bacterium Rhodobacter capsulatus. He is the founder of GeneBiologics, a company dedicated to the optimization of enzymes involved in green energy production.
Prior to working in the area of hydrogen production from microbes, Dr. Wecker discovered heme-binding oxygen-sensor protein homologs in C. reinhardtii. Previous to this, he worked on the in vitro evolution of RNA for the selection of catalytic RNAs capable of creating drug leads; this work was carried out at two Denver-area companies: Invenux, Inc., and NeXstar Pharmaceuticals. He holds a Ph.D. in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder, where he also worked on the in vitro RNA evolution of aptamers. He holds an M.S. from Cornell University, where he researched the production of acetaldehyde from bacteria. The idea was to short-sheet the ethanol fermentation pathway to produce acetaldehyde instead of ethanol; pure acetaldehyde boils at room temperature and wouldn't require an expensive distillation step for collection. Dr. Wecker's expertise includes in vitro evolution of RNA aptamers and RNA enzymes, RNA biosynthesis and modification, bioconjugation of linkers and activated chemical groups to RNA, and DNA and RNA structural analysis.
"High-throughput biosensor discriminates between different algal H2-photoproducing strains," Biotechnol. Bioeng. (2014)
"Novel FixL homologues in Chlamydomonas reinhardtii bind heme and O2," FEBS Lett. (2012)
"Design of a new biosensor for algal H2 production based on the H2-sensing system of Rhodobacter capsulatus," Int. J. Hydrogen. Energy (2011)
"In vitro selection of RNA ligands to substance P," Biochem. (1995)
"Fermentation strategies: Acetaldehyde or ethanol?," Process Biochem. (1987)
"The production of acetaldehyde using Zymomonas mobilis," Appl. Envir. Microbiol. (1987)
View all NREL Publications for Matt Wecker.